The birth and growth of nanotechnology is only a few decades old, whereas Nature has been building nano-machines for millennia. Viruses are marvels of natural nano-engineering, but can pose a problem for human health. To combat these nano-machines, scientists are turning to recent developments in nanotechnology to prevent infection and cure disease.
Carolyn Bertozzi is the T.Z. and Irmgard Chu Distinguished Professor of Chemistry and Professor of Molecular and Cell Biology at UC Berkeley, an Investigator of the Howard Hughes Medical Institute, and Director of the Molecular Foundry, a nanoscience institute at the Lawrence Berkeley National Laboratory. She completed her undergraduate degree in Chemistry from Harvard University in 1988 and her Ph.D. in Chemistry from UC Berkeley in 1993. After completing postdoctoral work at UCSF in the field of cellular immunology, she joined the UC Berkeley faculty in 1996.
Prof. Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface glycosylation pertinent to disease states. Her lab focuses on profiling changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and exploiting this information for development of diagnostic and therapeutic approaches. In addition, her group develops nanoscience-based technologies for probing cell function and for medical diagnostics.
Sally Nasman, Organizer
Nano*High gratefully acknowledges QB3, the California Institute for Quantitative Biosystems for providing the lecture hall on the University of California Berkeley campus.
Researchers should cite this work as follows:
1. University of California, Berkeley 2. Massachusetts Institute of Technology